Mimedx (MDXG) Receivables - Other (2017 - 2024)

Mimedx has disclosed Receivables - Other across 8 years of filings, most recently posting $1.0 million for Q4 2024.

• In Q4 2024, Receivables - Other changed 0.0% year-over-year to $1.0 million; the TTM figure through Dec 2024 stood at $1.0 million (changed 0.0% YoY), while the FY2024 annual figure was $1.0 million, changed 0.0% from the prior year.
• Receivables - Other came in at $1.0 million for Q4 2024 at Mimedx, roughly flat from $1.0 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $1.6 million in Q4 2021 to a low of $200000.0 in Q4 2020.
• Average Receivables - Other over 5 years is $862500.0, with a median of $850000.0 recorded in 2021.
• Year-over-year, Receivables - Other tumbled 84.62% in 2020 and surged 700.0% in 2021.
• Over 5 years, Receivables - Other stood at $200000.0 in 2020, then surged by 700.0% to $1.6 million in 2021, then declined by 12.5% to $1.4 million in 2022, then declined by 28.57% to $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024.
• Per Business Quant data, the three most recent Receivables - Other figures were $1.0 million in Q4 2024, $1.0 million in Q4 2023, and $1.4 million in Q4 2022.